Dr. Bhuvan Chugh

Dr. Bhuvan Chugh is a Lead Consultant in Medical Oncology at Indraprastha Apollo Hospital in New Delhi, bringing over 15 years of clinical excellence to cancer care. He holds qualifications in MBBS, DNB (Medicine), and DNB (Medical Oncology), establishing a robust foundation in internal medicine and specialized oncology practice. Dr. Chugh is recognised for his evidence-based, empathetic approach to patient care, underpinned by a commitment to clarity and confidence in medical decision-making.

Dr. Chugh specialises in breast cancer and thoracic cancer management, with particular expertise in chemotherapy, cancer immunotherapy, targeted therapy, and hormone therapy for breast cancers. A key focus of his practice is precision-led oncology—integrating genomic sequencing and molecular oncology findings to guide personalised treatment strategies. His notable clinical work includes CSF-based genomic sequencing management in EGFR-mutant lung cancer with leptomeningeal disease, presented at ALKlinic 2025 and published in the Journal of Liquid Biopsy. He previously served as Principal Consultant at Max Super Specialty Hospital (Saket and Gurugram), and as Past Convenor of the Max Healthcare–Foundation Medicine India Molecular Tumor Board, contributing to multidisciplinary oncology decision-making.

Dr. Chugh treats a diverse international patient population, including patients from the Gulf region, Africa, and South Asia seeking specialist cancer care. His fluency in English and Hindi ensures clear communication with patients across borders. He is an active member of leading international oncology societies—American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO), and International Association for the Study of Lung Cancer (IASLC)—keeping his practice aligned with global standards. His work has been presented at ASCO and ESMO conferences, and he was recognised with the ESMO Asia 2024 Best Poster Award.

Indraprastha Apollo Hospital, where Dr. Chugh practices, is a major tertiary-care centre in the Delhi–NCR region with state-of-the-art oncology infrastructure, advanced molecular diagnostics, and dedicated international patient services. The hospital's affiliation with Apollo Athenaa Women's Cancer Centre further strengthens its breast cancer management capabilities. International patients choosing Dr. Chugh benefit from a hospital ecosystem designed to support complex cancer cases, alongside a physician who practises evidence-based protocols informed by global oncology consensus. For patients seeking specialist oncology care with molecular precision and a patient-first philosophy, Dr. Chugh at Apollo Hospitals offers continuity, expertise, and access to cutting-edge diagnostic and therapeutic options.